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(NKG2D) and the signaling-competent adaptor DNAX-activating protein 10 (DAP10), which together play
an important role in antitumor immune surveillance. Ligand stimulation induces the internalization of
NKG2D-DAP10 complexes and their delivery to lysosomes for degradation. In experiments with human
NK cells and cell lines, we found that the ligand-induced endocytosis of NKG2D-DAP10 depended on
the ubiquitylation of DAP10, whichwas also required for degradation of the internalized complexes. More-
over, through combined biochemical and microscopic analyses, we showed that ubiquitin-dependent re-
ceptor endocytosis was required for the activation of extracellular signal–regulated kinase (ERK) and NK
cell functions, such as the secretion of cytotoxic granules and the inflammatory cytokine interferon-g.
These results suggest that NKG2D-DAP10 endocytosis represents a means to decrease cell surface re-
ceptor abundance, as well as to control signaling outcome in cytotoxic lymphocytes.http
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Cytotoxic lymphocytes are major players in the immune surveillance of
cancer, because they selectively kill malignant cells as a result of their abil-
ity to recognize molecules induced by neoplastic transformation. Different
subsets of human cytotoxic lymphocytes, including natural killer (NK)
cells, CD8+ ab T cells, and gd T cells, share the presence of the activating
receptor NK receptor group 2, member D (NKG2D), which stimulates ef-
fector responses upon binding to its ligands (NKG2DLs): major histocom-
patibility complex (MHC) class I–related chain (MIC) A (MICA) andMICB,
and UL16-binding proteins (ULBP1 to ULBP6) (1, 2). The increase in the
cell surface abundances of NKG2DLs is driven by genotoxic stress and
other forms of stress that are associated with malignant transformation (3),
thus rendering damaged cells susceptible to NKG2D-mediated cellular
cytotoxicity (4). The prominent role of this receptor in antitumor immune
surveillance has been demonstrated by experiments with murine tumor
models and NKG2D-deficient mice (5, 6).
NKG2D is a C-type lectin receptor, which is composed of two disulfide-
linked type II transmembrane glycoproteins bearing a short intracellular
tail that is not endowed with signaling capacity. Thus, to propagate signals,
human NKG2D needs to couple to the transmembrane adaptor DNAX-
activating protein 10 (DAP10), which together form a hexameric structure
composed of one NKG2D homodimer assembled with two DAP10 homo-
dimers (7). DAP10 contains in its cytoplasmic domain a tyrosine-based
motif (YINM) that is involved in the recruitment of phosphatidylinositol
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www.protein 2 (Grb2) and the guanine nucleotide exchange factor Vav1 (8–10).
This activating motif is similar to those found in costimulatory receptors,
such as CD28, inducible costimulator (ICOS), and CD19 (11, 12). Indeed,
NKG2D provides a costimulatory rather than a stimulatory signal to acti-
vated T cells, acting in concert with other costimulatory molecules to mod-
ify the strength and duration of antigen-specific responses mediated by the
T cell receptor (TCR). In NK cells, the functional outcome is the result of
the integration of signals from a broad array of activating and inhibitory
receptors (13, 14), and NKG2D functions either as costimulatory or a
stimulatory receptor depending on the activation status of the cell (15).
Activation of NKG2D on NK cells contributes to the innate immune re-
sponse through the ability of the receptor to stimulate cytotoxicity against
NKG2DL-bearing target cells, as well as to induce the production of var-
ious chemokines and cytokines, including interferon-g (IFN-g) (16).
Numerous studies have reported that persistent exposure to NKG2DLs
located on the surface of tumor cells, or released either in exosomes or as
soluble molecules by proteolytic shedding, can decrease the cell surface
abundance of receptors, which leads to the impairment of NKG2D-
dependent antitumor functions of both NK cells and CD8+ T cells (17–21).
Receptor internalization and degradation upon ligand binding is a well-
documented means to dampen immune responses and excessive inflam-
mation: by limiting the availability of activating receptors on the cell surface,
cells become refractory to additional stimuli. Internalization and degrada-
tion of several immune receptors are dependent on the ubiquitin pathway
(22–26). In addition, endocytosis of some membrane receptors is now rec-
ognized as an important route that is instrumental for signal transduction
(27, 28). Several studies conducted on receptor tyrosine kinases (RTKs) and
heterotrimeric guanine nucleotide–binding protein (G protein)–coupled re-
ceptors (GPCRs) have demonstrated that endocytosis is required to bring
activated receptors in close proximity to key signaling components, in-
cluding mitogen-activated protein kinases (MAPKs), located in endosomes,
thereby enabling signal propagation (29–34).
In the case of immune receptors, endosomes could participate in both
B cell and T cell signaling (35–39); however, little is currently knownSCIENCESIGNALING.org 27 October 2015 Vol 8 Issue 400 ra108 1
R E S E A R C H A R T I C L Eabout the role that immune receptor endocytosis plays in controlling sig-
naling and the functional responses of immune cells. With respect to the
NKG2D-DAP10 complex, we previously demonstrated that NKG2D in
human NK cells is subjected to internalization and subsequent lysosomal deg-
radation upon ligand binding and that this process depends on ubiquitylation
(26); however, whether DAP10 can undergo ubiquitylation and whether
receptor endocytosis contributes to signaling are unclear. Here, we found
that the engagement of NKG2D on NK cells resulted in the ubiquitylation
of DAP10, which was required for the endocytosis and degradation of the
NKG2D-DAP10 complex. Moreover, we demonstrated that signaling was
initiated at the plasma membrane and then continued after the engaged
NKG2D-DAP10 complexes were internalized and had trafficked to endo-
somes, which led to NK cell functional responses. o
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 RESULTS
DAP10 undergoes ubiquitylation upon NKG2D engagement
We previously demonstrated the contribution of the ubiquitin pathway
in the internalization and degradation of NKG2D upon stimulation with
MICA-expressing target cells (26). Here, we investigated whether the NKG2D-
DAP10 complex underwent ubiquitylation. Because of the difficulty in de-
tecting endogenous DAP10 with commercially available antibodies, we
transfected the human NK cell line NKL with a plasmid encoding a green
fluorescent protein (GFP)–tagged wild-type DAP10 to generate a stable cell
line (DAP10WT-GFP NKL cells). These cells were mixed with target Ba/F3
cells expressing MICA (Ba/F3-MICA cells) at a 1:1 ratio, and after stimu-
lation, DAP10 was immunoprecipitated from the NKL cell lysates with an
anti-GFP monoclonal antibody (mAb) (Fig. 1A). After 1 min of coincuba-
tion, in addition to a band corresponding to the DAP10-GFP fusion pro-
tein (~37 kD), Western blotting analysis revealed the presence of a specific
activation-induced form of molecular mass ~45 kD, which was compatible
with the addition of a single ubiquitin moiety (8.5 kD) and is characteristic
of monoubiquitylation. The anti-ubiquitin mAb FK2 detects both mono-
and polyubiquitylated proteins (40), and in our hands, it recognized a band
migrating at ~45 kD, which suggested that DAP10 was monoubiquitylated
(Fig. 1A). Moreover, additional bands of higher molecular mass were also
detected with the anti-ubiquitin antibody (Fig. 1A). These bands could
correspond to polyubiquitylated forms of DAP10 that were not revealed with
the anti-GFP antibody because of their low abundance, or to ubiquitylated
proteins that coimmunoprecipitated with DAP10. Samples subjected to im-
munoprecipitation with an isotype-matched control antibody did not show
any reactivity at ~45 kD or greater (Fig. 1A). To confirm that DAP10 under-
went ubiquitylation, we performed an in vitro ubiquitylation assay in which
GFP-tagged DAP10 was immunoprecipitated from unstimulated DAP10WT-
GFP NKL cells (Fig. 1B). We observed a similar pattern of bands to
those seen earlier (Fig. 1A). Together, these results indicate that DAP10 is
ubiquitylated.
The amino acid residue sequence of DAP10 contains only one lysine
residue (Lys84) (Fig. 1C). To investigate the role of DAP10 ubiquitylation,
we generated an NKL cell line expressing a DAP10-GFP fusion protein in
which Lys84 of DAP10 was mutated to an arginine (DAP10K84R). We first
verified that this mutation did not alter the ability of DAP10(K84R) pro-
teins to bind to NKG2D or to undergo phosphorylation in response to
engagement of NKG2D (fig. S1, A and B). Furthermore, flow cytometric
analysis revealed that comparable amounts of wild-type and mutant DAP10-
GFP fusion proteins were present in both cell lines and that the DAP10
mutant did not alter the amount of cell surface NKG2D or that of other
activating receptors not associated with DAP10, such as 2B4 (fig. S1C).
We then compared the pattern of DAP10 ubiquitylation in cells expressingwww.either wild-type DAP10 or DAP10(K84R) (Fig. 1D). After 1 min of stim-
ulation of the NKL cell lines with anti-NKG2D mAb, there was a substan-
tial decrease in the intensity of the bands detected by the anti-ubiquitin
antibody in samples from the DAP10(K84R)-GFP cells compared to those
from the DAP10WT-GFP cells (Fig. 1D). These results indicate that Lys84
is the site of ubiquitylation of DAP10, and support the conclusion that theFig. 1. DAP10 is ubiquitylated
on Lys84 upon NKG2D en-
gagement. (A) DAP10WT-GFP
NKL cells and paraformaldehyde
(PFA)–fixed Ba/F3-MICA cells
were mixed at a 1:1 ratio, centri-
fuged for 1 min at 100g to enable
conjugate formation, and then left
on ice (−) or incubated for the in-
dicated times at 37°C. Lysates
were immunoprecipitated (IP)
with anti-GFP mAb or isotype-
matched mAb (Ctrl). Immuno-
precipitates were then analyzed
by Western blotting with anti-GFP
antibody (left) before being stripped
and analyzed with anti-ubiquitin
mAb (right). (B) DAP10WT-GFP
NKL cell lysates were subjectedSCIENCESIGNALING.org 27 October 2015to immunoprecipitation with anti-GFP antibody coupled to protein G–
Sepharose beads. Immunoprecipitates and anti-GFP–conjugated protein
G–Sepharose beads alone were incubated with or without rabbit reticulocyte
lysate (RRL) in ubiquitylation buffer at 30°C for 2 hours. Samples were then
washed with lysis buffer, resolved by SDS–polyacrylamide gel electro-
phoresis (PAGE), and analyzed by Western blotting with the indicated
antibodies. (C) Amino acid sequence of the human DAP10 protein.
The transmembrane region is underlined, the putative site of ubiquitylation
(K) is circled, and the activating YINM motif is in bold. (D) DAP10WT-GFP
and DAP10(K84R)-GFP NKL cells were incubated with anti-NKG2D mAb
and then left on ice (−) or incubated with goat anti-mouse IgG for 1 min at
37°C to activate NKG2D. Cell lysates were then subjected to immuno-
precipitation and Western blotting analysis as described for (A). Black ver-
tical lines indicate noncontiguous blots. All Western blots are representative
of two independent experiments.Vol 8 Issue 400 ra108 2
R E S E A R C H A R T I C L Eforms of higher molecular mass mainly represent polyubiquitylated
DAP10 species.
The DAP10(K84R) mutant inhibits both the internalization
and degradation of NKG2D-DAP10
To assess the effect of the K84R mutation on NKG2D-DAP10 internal-
ization, we analyzed NKL transfectants using fluorescence microscopy
upon stimulation with an anti-NKG2D mAb. In unstimulated cells, a
uniform distribution of GFP was observed over the whole plasma mem-
brane in cells expressing either DAP10WT-GFP or DAP10(K84R)-GFP
(Fig. 2A). After 15 min of stimulation, DAP10WT-GFP protein was clearlywww.
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 detected inside the cells, whereas DAP10(K84R)-GFP appeared to be
clustered but was still associated with the plasma membrane (Fig. 2A).
Analysis at a later time (30 min) revealed that DAP10WT-GFP was inter-
nalized in about 80% of cells, whereas DAP10(K84R)-GFP was still lo-
calized in clusters on the plasma membrane in most cells (Fig. 2, A and
B). Similar results were obtained by analyzing NKG2D internalization in
cells expressing either DAP10WT-GFP or DAP10(K84R)-GFP 30 min
after stimulation (Fig. 2C), thus suggesting that mutation of DAP10
ubiquitylation site prevents the endocytosis of the engaged NKG2D-
DAP10 complex.
We previously demonstrated that stimulated NKG2D is internalized
and then subjected to lysosomal degradation (26). Consistent with this find-
ing, we found that engagement of NKG2D resulted in the degradation of
both DAP10 and NKG2D in cells expressing DAP10WT-GFP, as revealed
by decreased band intensities in samples from cells stimulated for 15 min
(Fig. 3, A and B). In contrast, receptor degradation was less substantial in cells
expressing DAP10(K84R). The lack of a complete inhibition of NKG2D
degradation in DAP10(K84R)-expressing cells might be explained by the
presence of an additional internalization motif within the cytoplasmic tail
of NKG2D but may also depend on the internalization and degradation of
NKG2D that was associated with endogenous DAP10. Together, these
results support a role for DAP10 ubiquitylation in driving NKG2D-DAP10
internalization and sorting to lysosomes for degradation.
DAP10 ubiquitylation is required for NKG2D-mediated
ERK1/2 activation and NK cell functions
Several studies showed that the endocytosis of activated receptors is re-
quired not only to decrease their cell surface abundance but also to form
specialized molecular platforms responsible for additional signal outputs
(31–33); however, whether NKG2D internalization is necessary for signal o
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DAP10 complex. (A) DAP10WT-GFP and DAP10(K84R)-GFP NKL cells,
as indicated, were incubated with anti-NKG2D mAb and then were left un-
treated on ice (0) or were incubated with goat anti-mouse antibody for the
indicated times at 37°C. The cells were then plated on poly-L-lysine–coated
coverslips, fixed, and washed before the coverslips were mounted and
analyzed by fluorescence microscopy. Representative images of single
cells are shown as a single optical section. Right: Differential interference
contrast (DIC) images overlaid on the DAP10-GFP fluorescence images.
Scale bar, 5 mm. Images are representative of three independent experi-
ments. (B) The percentages of cells showing DAP10 internalization at
the indicated times were calculated by analyzing randomly acquired fields
for each time point (n = 40 cells). Data are means ± SD of three
independent experiments. **P < 0.01; ***P < 0.005 by Student’s t test.
(C) DAP10WT-GFP and DAP10(K84R)-GFP NKL cells were incubated with
anti-NKG2D mAb and then stimulated with Alexa Fluor 350–conjugated
goat anti-mouse IgG (red) for 30 min at 37°C. GFP fluorescence is in
green. An overlay of the two-color merged images and the DIC image are
also shown.Scalebar, 5mm. Imagesare representativeof three independent
experiments.Fig. 3. DAP10 ubiquitylation is required for degradation of the NKG2D-
DAP10 complex. (A and B) DAP10WT-GFP and DAP10(K84R)-GFP NKL
cells were left unstimulated or were incubated with anti-NKG2D mAb and
goat anti-mouse IgG for the indicated times. Left: Whole-cell lysates were
then analyzed by Western blotting with the indicated antibodies. Black
vertical lines indicate noncontiguous blots. Western blots are from a
single experiment and are representative of three experiments. Right:
The abundances of the DAP10 (A) and NKG2D (B) proteins, normalized
to that of ZAP70, were determined by densitometric analysis and are
expressed relative to the protein abundances of unstimulated cells (arbi-
trarily set to 1). Data are means ± SD of three independent experiments.
*P < 0.05 by Student’s t test.SCIENCESIGNALING.org 27 October 2015 Vol 8 Issue 400 ra108 3
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 propagation that leads to NK cell effector
functions is unclear. To address this, we first
compared the amounts of IFN-g secreted
by DAP10WT-NKL and DAP10(K84R)-
NKL cells upon NKG2D engagement. Full
activation of the NK cell functional program
results from the cooperation of more than
one activating receptor (41); therefore, we
stimulated NKG2D alone or in combination
with stimulation of the activating receptor
2B4. Whereas stimulation with plate-bound
anti-NKG2D or anti-2B4 mAb alone failed
to stimulate either cell line to secrete IFN-g,
the coengagement of both NKG2D and 2B4
led to IFN-g production by DAP10WT-NKL
cells, but not DAP10(K84R)-NKL cells
(Fig. 4A).
We obtained similar results from experi-
ments in which we analyzed the secretion
of cytotoxic granules in response to the stim-
ulation of NKL cell transfectants with FcR+
P815 target cells that were coated with anti-
NKG2D or anti-2B4 mAbs (Fig. 4B), or
with Ba/F3-MICA cells and Ba/F3-CD48
cells to coengage NKG2D and 2B4 (fig.
S2). The percentage of DAP10WT-GFP
NKL cells that showed translocation of
the cytolytic granule marker CD107a from
the inner membrane of granules to the cell
surface upon degranulation was substan-
tially greater than that of similarly treated
DAP10(K84R)-GFP NKL cells (Fig. 4B).
The observed differences were not the result
of a general intrinsic functional defect of
the DAP10(K84R)-expressing cells, because
stimulation of these cells with interleukin-2
(IL-2) or phorbol 12-myristate 13-acetate (PMA)
and ionomycin induced similar functional re-
sponses in DAP10WT- and DAP10(K84R)-
expressing cells (Fig. 4B).
To evaluate whether the impairment of
NKG2D-mediated effector functions ob-
served in the DAP10(K84R)-GFP NKL cells
was a result of a defect in signal propaga-
tion, we assessed the phosphorylation events
downstream of activation of NKG2D. After
NKG2D engagement, Vav1 and the p85 reg-
ulatory subunit of PI3K are activated upon
their recruitment to the phosphorylated YINM
motif of DAP10 (9–11). We found that the
extent of phosphorylation of both p85 and
Vav1 was similar between DAP10WT-GFP
NKL cells and DAP10(K84R)-GFP NKL
cells (Fig. 4, C and D), which suggested that
early signaling events were not adversely
affected by the mutation of DAP10. Among
the signaling molecules involved in the ac-
tivation of NK cell functions, the MAPKs
extracellular signal–regulated kinases
1 and 2 (ERK1/2) play a key role in bothFig. 4. IFN-g release, cytotoxic granule exocytosis, and ERK1/2 activation are impaired in DAP10(K84R)-
NKL cells. (A) DAP10WT-GFP and DAP10(K84R)-GFP NKL cells were stimulated overnight with plate-
bound anti-NKG2D and anti-2B4 mAbs alone or in combination, or with IL-2 (1000 U/ml). The amounts
of IFN-g released into the cell culture media were measured by enzyme-linked immunosorbent assay
(ELISA). Data are means ± SD of three independent experiments. *P < 0.05. (B) DAP10WT-GFP and
DAP10(K84R)-GFP NKL cells were stimulated for 2 hours with P815 cells that were coated with anti-
NKG2D or anti-2B4 mAbs alone or in combination, or were treated with PMA (50 ng/ml) and ionomycin
(Iono) (500 ng/ml). Cell surface expression of CD107a was determined by flow cytometric analysis of GFP+
cells, and data are expressed as the percentage of GFP+ cells that were CD107a+. Data are means ± SD
of three independent experiments. *P < 0.05. (C and D) Left: DAP10WT-GFP and DAP10(K84R)-GFP NKL
cells were left unstimulated or were incubated with anti-NKG2D mAb and goat anti-mouse IgG for the
indicated times. Cell lysates were then subjected to immunoprecipitation with anti-p85 mAb or with
isotype-matched mAb (Ctrl). Immunoprecipitates (C) or total cell lysates (D) were then analyzed by West-
ern blotting with the indicated antibodies. Blots are representative of three independent experiments. Right:
The ratios of the abundances of the indicated pairs of total and phosphorylated proteins were determined
by densitometric analysis. Data are means ± SD of three independent experiments. *P < 0.05 by Student’s
t test.www.SCIENCESIGNALING.org 27 October 2015 Vol 8 Issue 400 ra108 4
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 the exocytosis of cytolytic granules and the
secretion of IFN-g (42–45). Therefore, we
also compared the ERK1/2 activation status
in the different NKL cell lines. We found
that ERK1/2 phosphorylation in DAP10WT-
GFP NKL cells was induced at 1 min after
stimulation with anti-NKG2D antibody,
peaked at 5 min, and then started to decrease
after 10 min (Fig. 4D, bottom); however, there
was a marked reduction in the phosphoryl-
ation of ERK1/2 in the DAP10(K84R)-GFP
NKL cells, which suggests that DAP10
ubiquitylation was required for the full ac-
tivation of ERK1/2 in response to NKG2D
stimulation.
The ERK pathway targets specific compo-
nents of the cytoskeleton (46); thus, we inves-
tigated whether impaired endocytosis of the
NKG2D-DAP10 complex in DAP10(K84R)-
GFP NKL cells was a consequence of the
defect in ERK1/2 activation. We found that
NKG2D-DAP10 complexes were internal-
ized to a similar extent in DAP10WT-GFP
NKL cells treated with vehicle or the MAPK
kinase 1 (MEK1) inhibitor PD098059, which
suggests that ERK activation was not in-
volved in receptor endocytosis (fig. S3). To-
gether, these results suggest that DAP10
ubiquitylation is required not only for the
lysosomal degradation of NKG2D and
DAP10 but also for ERK1/2 activation and
NK cell effector functions.
NKG2D endocytosis is required
for the activation of ERK1/2
Because the DAP10(K84R) mutant was
much less efficient than its wild-type counter-
part in mediating NKG2D internalization
and ERK1/2 phosphorylation, we postulated
that the endocytosis of the NKG2D-DAP10
complex might be required for ERK activa-
tion. To determine whether the inhibition
of NKG2D internalization affected signal
propagation and NK cell functional response,
we treated primary cultured human NK cells
with dynasore, a selective inhibitor of the
guanosine triphosphatase (GTPase) dynamin,
which blocks both clathrin-dependent and
clathrin-independent endocytosis (47). By
microscopic analysis, we observed that the
inhibitor efficiently blocked receptor endo-
cytosis induced by crosslinking with the
anti-NKG2D mAb (Fig. 5A). Moreover, we
found that dynasore inhibited the release of
CD107a+ cytolytic granules induced by the
engagement of NKG2D or 2B4 either alone
or in combination (Fig. 5B). Similar results
were obtained upon stimulation of primary
human NK cells with Ba/F3-MICA target
cells (fig. S4). Dynasore-treated primaryFig. 5. Dynasore impairs cytotoxic granule exocytosis and ERK1/2 activation in primary cultured NK cells.
(A) Primary cultured human NK cells were preincubated for 30 min in RPMI containing 100 mM dynasore or
dimethyl sulfoxide (DMSO) at 37°C. Cells were then stimulated and analyzed as described for Fig. 2C.
Scale bar, 5 mm. Images are representative of four independent experiments. (B) Primary cultured human
NK cells were treated with 100 mM dynasore or DMSO for 30 min and then were incubated for 2 hours with
P815 cells that were coated with anti-NKG2D or anti-2B4 mAbs alone or in combination, as indicated, or
were treated with PMA and ionomycin. Cell surface expression of CD107a was determined by flow cyto-
metric analysis of CD56+CD3− cells, and data are expressed as the percentage of CD56+CD3− cells that
were CD107a+. Data are means ± SD of four independent experiments. *P < 0.05. (C) Primary cultured
human NK cells were treated with 100 mM dynasore or DMSO for 30 min and then were left unstimulated or
were incubated with anti-NKG2D mAb and goat anti-mouse IgG for the indicated times. Left: Cell lysates
were analyzed by Western blotting with the indicated antibodies. The black vertical lines indicate non-
contiguous blots, whereas dashed vertical lines indicate repositioned lanes from the same blot. Right:
The ratios of the abundances of the indicated pairs of total and phosphorylated proteins were determined
by densitometric analysis. Data are means ± SD of three independent experiments. *P < 0.05 by Student’s
t test.www.SCIENCESIGNALING.org 27 October 2015 Vol 8 Issue 400 ra108 5
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 NK cells did not show general defects in granule exocytosis because they
responded to PMA and ionomycin, a nonspecific stimulatory signal (Fig. 5B).
Treatment of primary NK cells with dynasore had no effect on the ex-
tent of phosphorylation of either Vav1 or Akt in response to stimulation
with an anti-NKG2D antibody (Fig. 5C); however, primary NK cells treated
with the inhibitor showed a defect in ERK1/2 phosphorylation (Fig. 5C),
which was comparable to the defect observed in DAP10(R84R)-GFP
NKL cells (Fig. 4D). We then used a small interfering RNA (siRNA)–based
approach combined with confocal microscopy and biochemical analysis.
Transfection of parental NKL cells with dynamin 2–specific siRNA led to
about a 60% reduction in the abundance of dynamin 2 compared to that in
cells transfected with nontargeting control siRNA (Fig. 6A). Consistent
with the results obtained from the experiments with dynasore, knockdown
of dynamin 2 reduced the extent of NKG2D endocytosis (Fig. 6B) and
ERK1/2 phosphorylation (Fig. 6C) upon receptor stimulation. Together,
our results indicate that ERK1/2 activation and NK cell effector functions
depend on the endocytosis of NKG2D, which suggests that the distribu-
tion of activated receptor complexes in endosomal compartments enables
signal propagation.
Phosphorylated ERK1/2 and internalized NKG2D-DAP10
complexes colocalize with early endosomes upon
receptor engagement
Several studies have demonstrated that the activation of the ERK signaling
pathway can take place in endosomes (29–34). To study whether phos-
phorylated ERK1/2 (pERK) and internalized NKG2D-DAP10 complexes
accumulated in early endosomal compartments, we performed double stain-
ing of pERK and the endosomal marker EEA1 (early endosome antigen 1)
in DAP10WT-GFP NKL cells upon stimulation with anti-NKG2D mAb,
and we analyzed the colocalization of DAP10-GFP with EEA1-positive
endosomes. The signal corresponding to pERK increased upon NKG2D
stimulation; during the first 5 min of stimulation, we observed only a slight
increase in pERK immunostaining, which reached a maximum at 10 min
and declined at 15 min (fig. S5). Thus, colocalization between active
ERK1/2 and EEA1-positive endosomes was evaluated at these latter time
points. Colocalization was transient, reaching a maximum at 10 min (Fig. 7,
A and B, left), and decreasing at 15 min (Fig. 7B, left). In addition, we
found that the DAP10-GFP fusion proteins also colocalized with
EEA1-containing compartments with overlapping kinetics (Fig. 7, A and
B, left). Furthermore, the colocalization indexes for DAP10-GFP/EEA1
and pERK/EEA1 that were calculated for each cell at 10 min of stimula-
tion showed a positive correlation (R = 0.75; P < 0.0001) (Fig. 7B, right).
These results indicate that internalized NKG2D-DAP10 complexes and
pERK1/2 transiently localize in early endosomes, which suggests that re-
ceptor internalization may be required for the recruitment of ERK1/2 into
this compartment and for its activation.
DISCUSSION
Much evidence suggests that upon ligand binding, NKG2D-DAP10
complexes are internalized from the surface of NK cells and CD8+ T cells
and are subjected to subsequent degradation in lysosomes (17, 26, 48).
However, to date, little is known about the molecular mechanisms that con-
trol NKG2D-DAP10 endocytosis or about its possible connection with
downstream signaling. Here, we found that upon NKG2D engagement
on human NK cells, DAP10 was subjected to ubiquitylation (Fig. 1) and
that this modification was required for endocytosis of the NKG2D-DAP10
complex (Fig. 2). The involvement of the cytoplasmic domain of DAP10
in its internalization was previously reported in several studies, and tyro-
sine phosphorylation in the YINMmotif is indispensable for endocytosiswww.Fig. 6. Knockdown of dynamin 2 impairs ERK1/2 activation in NKL cells. (A)
NKL cells were transfected with dynamin 2–specific siRNA or with control
siRNA. Left: Forty-eight hours later, whole-cell lysates were analyzed by
Western blotting with the indicated antibodies. Middle: The amounts of
dynamin protein, normalized to that of ZAP70, were determined by den-
sitometric analysis and are relative to that in unstimulated cells (which was
arbitrarily set to 1). Data are means ± SD of three independent experi-
ments. Right: The amounts of dynamin2 mRNA, normalized to that of
GAPDHmRNA, were determined by quantitative reverse transcription poly-
merase chain reaction (qRT-PCR) analysis and are expressed as the fold
change relative to that in cells transfected with control siRNA. Data are
means ± SD of three independent experiments. (B) NKL cells transfected
with the indicated siRNAs were stimulated for 30 min at 37°C and analyzed
as described for Fig. 2C. Scale bar, 5 mm. (C) NKL cells transfected with
the indicated siRNAs were left unstimulated or were incubated at 37°C with
anti-NKG2D and goat anti-mouse IgG for the indicated times. Left: Whole-
cell lysates were analyzed by Western blotting with the indicated anti-
bodies. The black vertical lines indicate noncontiguous blots. Right: The
ratios of the abundances of the indicated pairs of total and phosphorylated
proteins were determined by densitometric analysis. Data are means ± SD
of three independent experiments. **P < 0.01, *P < 0.05 by Student’s t test.SCIENCESIGNALING.org 27 October 2015 Vol 8 Issue 400 ra108 6
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 (48, 49). Here, we demonstrated that in addition to phosphorylation of
DAP10, its ubiquitylation was also required for the endocytosis of engaged
receptor complexes. We further found that DAP10 ubiquitylation was essen-
tial for degradation of the NKG2D-DAP10 complex (Fig. 3), which is
consistent with a study that demonstrated that a chimeric protein in which
ubiquitin was fused to the C terminus of mouse DAP10 targeted DAP10-
ubiquitin and NKG2D for constitutive internalization and degradation (50).
The major finding of our study is that the ubiquitin-dependent endo-
cytosis of the engaged NKG2D-DAP10 complex was required for efficient
activation of NK cell effector functions, in terms of both cytolytic granule
exocytosis and IFN-g release (Fig. 4, A and B). Experiments with primary
NK cells in which endocytosis was inhibited showed that cytolytic granule
secretion induced by 2B4 engagement alone was substantially impaired
(Fig. 5B). Together, these results suggest that signaling from endosomal
compartments is required to enable full NK cell activation. With respect to
signaling, we found that receptor-proximal phosphorylation events did not
require receptor endocytosis (Figs. 4, C and D, 5C, and 6C). However, we
found that the phosphorylation of ERK1/2 was impaired in NK cells in
which endocytosis was inhibited (Figs. 4D, 5C, and 6C). Moreover, pERK
transiently associated with endosomal compartments in which internalized
DAP10-GFP fusion proteins were also present (Fig. 7).
Together, our findings led us to propose a model (fig. S6) in which the
ubiquitin-dependent internalization of NKG2D-DAP10 and its trafficking
along endosomes are required for the activation of ERK1/2 in endosomal
compartments before the receptors reach lysosomes and undergo degrada-
tion. We propose that pERK could then detach from endosomes or trans-
locate to the nucleus to reach its targets, thus enabling signal propagation
and the functional response. With regard to other immune receptors, there
is little evidence in support of a role of endosomal signaling. In the case of
the B cell receptor (BCR), intracellular trafficking of the receptor is im-
portant to control the correct extent of activation of the MAPK and Akt
signaling pathways and their downstream effects (35), and components
that activate c-Jun N-terminal kinase (JNK) are recruited in proximity
to active BCR in endosomes (36). Endosomes may also participate in
T cell signaling; upon TCR stimulation, there is an accumulation of phos-
phorylated CD3z in endosomes (37), and the phosphorylated adaptor pro-
tein LAT (linker of activated T cells) can be found in intracellular vesicles
(38). Moreover, TCR internalization ensures the appropriate signaling
strength that is required to promote the proliferation of mouse T cells
in vivo (39).
Different scenarios are exemplified by Toll-like receptor 4 (TLR4),
which activates diverse signaling pathways based on its location (at the cell
surface versus in endosomes) (51), and by killer cell immunoglobulin-like
receptor, two domains, long cytoplasmic tail, 4 (KIR2DL4), an activating
receptor found on NK cells and some T cell subsets, which accumulates in
early endosomes to initiate a proinflammatory cascade (52, 53). Endoso-
mal signaling has been extensively investigated in the cases of the RTK
and GPCR families, in which it controls processes such as proliferation,
differentiation, and inflammation (28). The rate of internalization of such
receptors is substantially higher than the rate of their lysosomal targeting
and degradation. As a consequence, there is a prolonged residence of these
signaling receptors in endosomes after ligand-induced endocytosis, and
signaling is sustained (54–57). With respect to NKG2D-DAP10, we found
that receptor internalization was rapidly followed by lysosomal degrada-
tion, suggesting that the contribution of endosomal signaling would serve
to guarantee signal propagation, rather than to sustain it. Indeed, in cytotoxic
lymphocytes, the exocytosis of cytolytic granules is a rapid process, which
is highly controlled and directed to the appropriate target.
In the context of an NK cell, for which the functional response is
the result of a delicate balance of signals from activating and inhibitoryFig. 7. Internalized DAP10 and pERK1/2 colocalize with EEA1-positive en-
dosomes in NKL cells. (A) DAP10WT-GFP NKL cells were incubated with
anti-NKG2D mAb and then were left untreated on ice (0) or were incubated
with goat anti-mouse antibody for 10 min at 37°C. The cells were then
plated on poly-L-lysine–coated coverslips, fixed, permeabilized, and incu-
bated with anti-pERK1/2 antibody followed by an Alexa Fluor 594–conjugated
goat anti-rabbit antibody (red), as well as with Pacific Blue–conjugated anti-
EEA1 rabbit antibody (blue). The coverslips were then washed, mounted,
and analyzed by confocal microscopy. Representative images of single
cells are shown as maximum intensity projections (six Z sections with
0.46-mm spacing). An overlay of the three-color merged image and the
bright-field image is also shown, and the fluorescence histograms of each
channel in the region of interest (ROI) (yellow line) are plotted. Scale bar,
5 mm. (B) Left: Percentage of colocalization of pERK1/2 with EEA1 and of
DAP10-GFP with EEA1 at the indicated times. Data are means ± SD of
colocalization indexes from three independent experiments (n = 29 cells)
calculated with FluoView software. Right: Scatter graph with regression line
to show the correlation between DAP10-EEA1 and pERK-EEA1 colocaliza-
tion indexes calculated in single cells after 10 min of stimulation (R = 0.75;
P < 0.0001). Each dot represents a single cell (n = 29 cells).SCIENCESIGNALING.org 27 October 2015 Vol 8 Issue 400 ra108 7
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platforms for the integration of synergistic signals triggered by different
engaged receptors, thus adding an extensive and complex level of func-
tional regulation. In conclusion, we demonstrated that the ubiquitin-
dependent endocytosis of an immune receptor served to regulate effector
functions, and we provided evidence that a cooperative interaction between
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Cell culture
The human NK cell line NKL was cultured in RPMI 1640 medium sup-
plemented with 10% fetal calf serum (FCS) and recombinant human IL-2
(200 U/ml; R&D Systems). All biochemical studies and IFN-g release
assays were performed with NKL cells after 24 hours of IL-2 deprivation.
Human NK cell cultures were obtained by coculturing peripheral blood
mononuclear cells with irradiated RPMI 8866 cells for 10 days at 37°C
in a humidified 5% CO2 atmosphere. On day 10, the cell population was
routinely 80 to 95% CD56+, CD16+, and CD3− as assessed by immuno-
fluorescence and flow cytometric analysis. Experiments were then performed
on NK cell populations that were >90% pure. The Ba/F3-MICA and Ba/
F3-CD48 cell lines were provided by L. L. Lanier (University of San Francisco)
and were maintained in RPMI medium supplemented with 10% FCS. The
P815 murine mastocytoma FcRg+ cell line was grown in RPMI medium
supplemented with 10% FCS.
NK cell stimulation
NKL cell stimulation (Fig. 1A) was performed with fixed Ba/F3-MICA
target cells. Briefly, target cells were treated with 1% PFA for 30 min at
room temperature, washed extensively in cold phosphate-buffered saline
(PBS), suspended in RPMI medium, and then added to the NKL cells.
The stimulation was stopped by washing with cold PBS, and lysis buffer
was added to both the effector and fixed target cells, whose lysis was
prevented by the pretreatment with 1% PFA, as previously reported (45).
For stimulation with anti-NKG2D antibody, NKL cells or primary cultured
NK cells were incubated with anti-NKG2DmAb (clone 149810, R&D Sys-
tems) for 30 min on ice. Goat anti-mouse antibody (Jackson ImmunoResearch)
was added and incubated at 37°C for the times indicated in the figure
legends. To visualize NKG2D by microscopic analysis, receptor engage-
ment was achieved with an Alexa Fluor 350–conjugated goat anti-mouse
IgG1 (Invitrogen). Pervanadate was freshly prepared by mixing 50 mM
vanadate and 50 mMH2O2 in PBS to give a 25 mM solution of pervanadate,
which was then diluted in cell culture medium to give a final concentration
of 1 mM. To inhibit endocytosis, primary cultured NK cells were pre-
treated at 37°C for 30 min with 100 mM dynasore (Sigma-Aldrich). To
inhibit ERK1/2 activation, NKL cells were incubated at 37°C for 1 hour
with the MEK1 inhibitor PD98059 (Millipore). Stimulation was conducted
in the presence of the respective inhibitors. Cell viability was >90% before
stimulation.
Plasmids, transfections, and siRNAs
The complementary DNA (cDNA) encoding full-length human Dap10
was subcloned from the total cDNA of the NKL cell line by RT-PCR assay
with gene-specific primers (forward: 5′-gagagatcttccaccatgatccatctgg-3′;
reverse: 5′-gtggatccctgcctggcatgttgatgt-3′), and the fragment was inserted
into the pEGFP-N1 vector (Clontech Laboratories) at the Bgl II andwww.Bam H1 sites to generate a construct encoding GFP fused to the C ter-
minus of DAP10. The DAP10(K84R)-GFP mutant was prepared by PCR
(QuikChange Site-Directed Mutagenesis Kit, Stratagene) using the pEGFP-
N1-DAP10-GFP plasmid as template and the following primers: forward,
5′-cgcccaagatggcagagtctacatcaacatgcc-3′; reverse, 5′-ggcatgttgatgtagactctgc-
catcttgggcg-3′. The integrity of the plasmid constructs was verified by DNA
sequence analysis. The plasmids were digested with Ase I, and NKL
cells were transfected with 2.5 mg of linearized plasmids with the Amaxa
4D-Nucleofector System, SF solution, program EO-100 (Lonza Group Ltd.).
Transfected cells were grown under selection with G418 (1 mg/ml), and
the bulk stable cells were sorted on the basis of GFP abundance with a
FACSAria sorter (BD Biosciences) equipped with a 488-nm laser and
FACSDiva software (version 6.1.3, BD Biosciences). Briefly, cells first gated
by forward and side scatter (FSC-A and SSC-A) were then detected in the
green fluorescence channel for comparable GFP abundance. Dynamin 2–
specific siRNA (5′-AAGGACCAGGCAGAAAACGAG-3′) and a con-
trol nontargeting siRNA (5′-UAAGGCUAUGAAGAGAUACUU-3′) were
purchased from Eurofins MWG Operon. Specific protein knockdown was
achieved by transfecting NKL cells with siRNA duplexes by electroporation
with an Amaxa 4D-Nucleofector System (Lonza). Briefly, 2 × 106 cells
were resuspended in 100 ml of Amaxa SF solution, mixed with 600 pmol
of siRNA, and transfected with program CM-137. Forty-eight hours after
transfection, the knockdown efficiency was evaluated by Western blotting
and qRT-PCR analyses.
RNA isolation and qRT-PCR analysis
Total RNA isolation and reverse transcription were performed as previously
described (58). Real-time PCR analysis was performed with TaqMan
assays and the ABI Prism 7900 Sequence Detection system (Applied Bio-
systems). The cDNAs were amplified in triplicate with primers specific
for dynamin 2 (Hs00974698_m1) conjugated with the fluorochrome FAM
(Applied Biosystems). The abundance of dynamin2 mRNAwas measured
as previously described (58), and all samples were normalized to the abun-
dance of GAPDH mRNA.
Immunoprecipitation and Western blotting analysis
Cells were lysed in a buffer (pH 7.5) containing 1% Triton X-100, 50 mM
tris-HCl (pH 7.5), 150 mM NaCl, 2.5 mM EGTA (pH 8), 2.5 mM EDTA
(pH 8), 1.5 mM MgCl2, 1 mM phenylmethylsulfonyl fluoride, 1 mM
Na3VO4, 5 mM NaF (pH 8), 5 mM N-ethylmaleimide, aprotinin (10 mg/ml),
and leupeptin (5 mg/ml). Immunoprecipitations were performed by bind-
ing the appropriate antibodies to protein A–Sepharose beads (Amersham
Pharmacia) or protein G–Sepharose beads (Sigma-Aldrich), and then in-
cubating them with equal amounts of protein from the cell lysates of each
sample. The immunoprecipitates were washed five times with lysis buffer,
and bound proteins were eluted with Laemmli buffer containing 5%
2-mercaptoethanol. Immunoprecipitates or total cell lysates were resolved
by SDS-PAGE and transferred to nitrocellulose filters. After undergoing
blocking of nonspecific reactivity, filters were incubated with specific pri-
mary and secondary antibodies diluted in TBS-T [20 mM tris-HCl (pH 7.8),
150 mM NaCl, 0.05% Tween 20]. After extensive washing, the immuno-
reactive bands were detected with an enhanced chemiluminescence detec-
tion kit (Amersham Pharmacia). The following antibodies were used for
immunoprecipitation and Western blotting: anti-GFP (Invitrogen); anti-
NKG2D (clone 3.1.1.1), anti-ZAP70, anti-phosphotyrosine, anti-Vav1, and
anti-p85 (all from Millipore); anti-Akt, anti-pAkt (S473), anti-ERK1/2,
and anti-pERK1/2(T202/Y204) (all from Cell Signaling Technology); anti-
ubiquitin (clone FK2, Enzo Life Sciences); anti–dynamin 2 (5E4C2F3,
Santa Cruz Biotechnology); and anti-pVav (Y160) (Life Technologies). Den-
sitometric analysis was performed with ImageJ software.SCIENCESIGNALING.org 27 October 2015 Vol 8 Issue 400 ra108 8
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 In vitro ubiquitylation assay
DAP10-GFP was immunoprecipitated from unstimulated DAP10WT-GFP
NKL cells and used as source of substrate for in vitro ubiquitylation as-
says. The immunocomplexes were washed five times with lysis buffer and
once with 1× ubiquitylation buffer [50 mM tris (pH 7.5), 0.5 mM MgCl2,
0.1 mM adenosine triphosphate, 0.1 mM dithiothreitol, 1 mM creatine
phosphate] and incubated in 40 ml of the same buffer supplemented with
70% (v/v) RRLs, creatine phosphokinase (10 U), and 10 mg of ubiquitin
for 2 hours at 30°C (23). After in vitro ubiquitylation, all samples were
washed three times with lysis buffer, eluted with SDS sample buffer, resolved
by SDS-PAGE, and transferred electrophoretically to nitrocellulose filters.
Immunofluorescence and microscopic analysis
NKL cells or primary cultured NK cells were stimulated with anti-
NKG2D mAb as described earlier. After stimulation, the cells were gently
resuspended, plated on poly-L-lysine–coated multichamber glass plates,
and fixed with 4% PFA. After extensive washing, the coverslips were
mounted with SlowFade Gold reagent (Life Technologies) and acquired
at room temperature with an ApoTome Observer Z.1 microscope with a
63×/1.4 NA (numerical aperture) Plan-Neofluar oil immersion objective
(Carl Zeiss), as previously described (59, 60). When colocalization anal-
ysis was required, cells were permeabilized with 0.1% Triton X-100 for
5 min to stain intracellular antigens, and were incubated with the following
antibodies diluted in blocking buffer (0.01% Triton X-100, 1% FCS): anti-
pERK1/2 (Cell Signaling Technologies) followed by an Alexa Fluor 594–
conjugated goat anti-rabbit antibody (Invitrogen); anti-EEA1 (Santa Cruz
Biotechnology), which was conjugated with Pacific Blue with an Anti-
body Labeling Kit (Life Technologies). High-resolution images (640 ×
640 pixel, 10 ms/pixel) were acquired with a FV1200 MPE laser-scanning
confocal microscope (Olympus) with a 60×/1.35 NA UPlanSAPO oil im-
mersion objective. Sequential acquisition was used to avoid crosstalk be-
tween different fluorophores. Quantification of colocalization was performed
with FluoView 4.2 software, considering colocalization indexes between
two channels on single cells (ROI) after background correction. Images
were processed with ImageJ software.
NK cell functional assays
Degranulation of NK cells was determined by detection of the cell surface
expression of CD107a, as previously described (41), with some modifi-
cations. Briefly, P815 cells (2 × 105) were incubated for 15 min at room
temperature with 2 mg of the following mAbs: anti-NKG2D (R&D Sys-
tems), anti-2B4 (Beckman Coulter), or both. NK cells (1 × 105) were then
mixed with P815, Ba/F3-MICA, or Ba/F3-CD48 cells, and the cells were
centrifuged for 1 min at 100g and incubated for 2 hours at 37°C. There-
after, cells were washed with PBS/5 mM EDTA, fixed with 2% PFA, and
stained with allophycocyanin (APC)–conjugated anti-CD107a mAb or
with isotope control (BD Biosciences) and, when primary NK cells were
used, with peridinin chlorophyll protein (PerCP)–conjugated anti-CD3 anti-
body and phycoerythrin (PE)–conjugated anti-CD56 mAbs (BD Biosciences).
Flow cytometric analysis was performed with a BD FACSCanto II flow
cytometer equipped with 488- and 633-nm lasers and with DIVA software
(BD Biosciences). NKL cells were gated on the basis of GFP abundance
(GFP+ cells), whereas primary NK cells were gated as CD3− and CD56+
cells. To measure IFN-g release by ELISA, NKL cells were stimulated
with IL-2 (1000 U/ml) or with plate-bound mAbs in flat-bottomed 96-well
plates in which the wells were coated with goat anti-mouse immuno-
globulin G (IgG) (2 mg per well in PBS) overnight at 4°C and then for
1 hour at 37°C with mAbs (1 mg per well in PBS). After washing, NKL
cells (2 × 105 cells per well in RPMI medium supplemented with 10%
FCS) were added onto the plates and were left overnight at 37°C beforewww.cell culture medium was collected. IFN-g concentrations were measured
with the human IFN-g ELISA kit (Thermo Scientific).
Statistical analysis
For normally distributed data, statistical significance of differences between
two groups was determined by performing two-tailed, paired Student’s t
tests. Data shown in graphs are means ± SD of at least three independent
experiments. Linear regression analyses were performed to determine cor-
relations between normally distributed data variables (colocalization indexes).
Correlations are presented by expressing the Pearson’s correlation coeffi-
cient R together with the P value for related statistical significance.SUPPLEMENTARY MATERIALS
www.sciencesignaling.org/cgi/content/full/8/400/ra108/DC1
Fig. S1. Characterization of the DAP10WT-GFP and DAP10(K84R)-GFP NKL cell lines.
Fig. S2. Cytotoxic granule exocytosis induced upon coengagement of NKG2D and 2B4 is
inhibited in DAP10(K84R)-GFP NKL cells.
Fig. S3. PD098059 does not inhibit DAP10 internalization in DAP10WT-GFP NKL cells.
Fig. S4. Dynasore impairs cytotoxic granule release by cultured primary NK cells in response
to stimulation with Ba/F3-MICA cells.
Fig. S5. Analysis of the kinetics of ERK1/2 phosphorylation by confocal microscopy.
Fig. S6. Proposed model of the molecular mechanisms underlying NKG2D-DAP10 endocy-
tosis and signaling in response to receptor engagement.REFERENCES AND NOTES
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